Print

American Society for Bone and Mineral Research: Bone Drug Raises Quality of Life, McMaster University Study  
10/19/2010 7:02:43 AM

MedPageToday -- TORONTO -- The osteoporosis drug zoledronic acid (Reclast) significantly increased health-related quality of life over and above its reduction in the fracture rate, a researcher said here.
//-->